CSECX
Price
$18.19
Change
-$0.06 (-0.33%)
Updated
Jul 31 closing price
Net Assets
3.35B
RGAAX
Price
$72.69
Change
+$0.84 (+1.17%)
Updated
Jul 31 closing price
Net Assets
356.86B
Interact to see
Advertisement

CSECX vs RGAAX

CSECX vs RGAAX Comparison Chart in %
View a ticker or compare two or three
VS
CSECX vs. RGAAX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CSECX is a StrongBuy and RGAAX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGAAX has more cash in the bank: 357B vs. CSECX (3.35B). CSECX pays higher dividends than RGAAX: CSECX (0.15) vs RGAAX (0.00). CSECX was incepted earlier than RGAAX: CSECX (32 years) vs RGAAX (24 years). CSECX (1.66) is less costly to investors than RGAAX (1.37). RGAAX is a more actively managed with annual turnover of: 32.00 vs. CSECX (14.00). RGAAX has a lower initial minimum investment than CSECX: RGAAX (250) vs CSECX (1000). RGAAX annual gain was more profitable for investors over the last year : -0.71 vs. CSECX (-46.36). RGAAX return over 5 years is better than : 4.80 vs. CSECX (-55.59).
CSECXRGAAXCSECX / RGAAX
Total Expense Ratio1.661.37121%
Annual Report Gross Expense Ratio1.661.37121%
Fund Existence32 years24 years-
Gain YTD-5.1125.135-100%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets3.35B357B1%
Annual Yield % from dividends0.150.00-
Returns for 1 year-46.36-0.716,527%
Returns for 3 years-48.5228.54-170%
Returns for 5 years-55.594.80-1,158%
Returns for 10 years-33.9278.47-43%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AIV2.690.03
+1.13%
Apartment Investment and Management Company
LOB42.800.34
+0.80%
Live Oak Bancshares
OGE47.350.09
+0.19%
OGE Energy Corp
CRACU10.25N/A
N/A
Crown Reserve Acquisition Corp. I
INKT10.50-0.09
-0.85%
MiNK Therapeutics Inc